Testing effectiveness (Phase 2)Active Not RecruitingNCT04101877What this trial is testingThe Sahlgrenska Anti-VEGF StudyWho this might be right forNeovascular Age-related Macular Degeneration Vastra Gotaland Region 402
Very early researchUnknownNCT05099094What this trial is testingVEGFA-targeting Gene Therapy to Treat Retinal and Choroidal Neovascularization DiseasesWho this might be right forNeovascular Age-related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion Shanghai BDgene Co., Ltd. 3
Not applicableEnded earlyNCT00474695What this trial is testingStudy Evaluating Genotypes Using LucentisWho this might be right forAge-Related Maculopathy University of Utah 65
Early research (Phase 1)Study completedNCT00782093What this trial is testingAscending and Parallel Group Trial to Establish the Safety, Tolerability and Pharmacokinetics Profile of Volociximab (Alpha 5 Beta 1 Integrin Antagonist) in Subjects With Neovascular Age- Related Macular DegenerationWho this might be right forAge-related Macular Degeneration Ophthotech Corporation 63
Post-approval studies (Phase 4)Study completedNCT02257632What this trial is testingSystemic Vascular Endothelial Growth Factor (VEGF) Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Neovascular Age-related Macular DegenerationWho this might be right forWet Age-Related Macular Degeneration Novartis Pharmaceuticals 41
Testing effectiveness (Phase 2)Study completedNCT03197493What this trial is testingExtension, Carbidopa-levodopa in Neovascular Age-related Macular Degeneration (AMD)Who this might be right forMacula; DegenerationRetina Snyder, Robert W., M.D., Ph.D., P.C. 35
Not applicableStudy completedNCT01103505What this trial is testingHOme Vision Monitoring in AREDS2 for Progression to Neovascular AMD Using the ForeseeHome DeviceWho this might be right forAge Related Macular Degeneration Notal Vision Ltd. 1,520
Not applicableStudy completedNCT00787319What this trial is testingLong-Term Non-Interventional Study (NIS) To Investigate The Safety And Effectiveness Of MACUGEN In Patients With Neovascular Age-Related Macular Degeneration Under Conditions Of Routine Clinical PracticeWho this might be right forAge-related Macular Degeneration Pfizer 108
Testing effectiveness (Phase 2)Study completedNCT05275205What this trial is testingSafety, Tolerability, and Efficacy Study of UBX1325 in Patients With Neovascular Age-Related Macular Degeneration (ENVISION)Who this might be right forNeovascular Age-related Macular Degeneration Unity Biotechnology, Inc. 51
Post-approval studies (Phase 4)UnknownNCT03468296What this trial is testingTwo-week Retreatment Interval Study for Treated Age-related Macular Degeneration Refractory to Monthly AfliberceptWho this might be right forNeovascular Age-related Macular Degeneration Tennessee Retina 22
Not applicableLooking for participantsNCT07005323What this trial is testingProgression Suppression and Retinal Regression in VEGF-resistant AMDWho this might be right forNeovascular Age-related Macular Degeneration (AMD) PharmaBio Corporation 10
Testing effectiveness (Phase 2)Study completedNCT03023059What this trial is testingDose Ranging Study of Carbidopa-levodopaWho this might be right forAge-related Macular Degeneration Snyder, Robert W., M.D., Ph.D., P.C. 35
Not applicableStudy completedNCT01334294What this trial is testingHome Vision Monitoring Using the ForeseeHome Device Following Treatment of Neovascular Age Related Macular DegenerationWho this might be right forAge Related Macular DegenerationChoroidal Neovascularization Notal Vision Ltd. 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT05536973What this trial is testingSafety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular Age-related Macular Degeneration [LUNA]Who this might be right forNeovascular Age-related Macular Degeneration Adverum Biotechnologies, Inc. 69
Large-scale testing (Phase 3)WithdrawnNCT05126966What this trial is testingThe Effectiveness And Safety Of A 36-Week Refill Regimen For The Port Delivery System With Ranibizumab Vs Aflibercept Treat & Extend In Subjects With Neovascular Age-Related Macular DegenerationWho this might be right forNeovascular Age-Related Macular Degeneration Hoffmann-La Roche
Early research (Phase 1)Study completedNCT02859766What this trial is testingSafety and Pharmacokinetics of Abicipar Pegol Intravitreal Injections in Patients With Neovascular AMDWho this might be right forMacular Degeneration Allergan 30
Not applicableNot Yet RecruitingNCT07088445What this trial is testingTherapeutic Prospects of Faricimab Injection for Patients Affected by Neovascular Age-Related Macular DegenerationWho this might be right forNeovascular Age-related Macular Degeneration(nAMD) Hui Peng 35
Large-scale testing (Phase 3)UnknownNCT05297292What this trial is testingEvaluate the Efficacy and Safety of MW02 in the Treatment of nAMDWho this might be right forWet Age-related Macular Degeneration Mabwell (Shanghai) Bioscience Co., Ltd. 433
Testing effectiveness (Phase 2)Active Not RecruitingNCT06660667What this trial is testingA Safety and Efficacy Study of One-time SAR402663 in Adults With Neovascular Age-related Macular DegenerationWho this might be right forNeovascular Age-related Macular Degeneration Sanofi 66
Not applicableActive Not RecruitingNCT07481500What this trial is testingSpeculum-Free Intravitreal Injection Using Cotton-Tipped Applicator Retraction: Pain, Procedure Time, Patient Satisfaction, and SafetyWho this might be right forNeovascular Age-Related Macular Degeneration (nAMD)Diabetic Macular EdemaRetinal Vein Occlusion+2 more Jakkrit Juhong 129